CT引导125I粒子植入治疗晚期非小细胞肺癌的应用

The image guided 125I seeds implantation treatment terminal non small cell lung carcinoma research of application

  • 摘要: 目的 分析研究125I粒子植入治疗晚期非小细胞肺癌(NSCLC)的疗效及不良反应。方法 对确诊的晚期NSCLC患者由放射治疗计划系统(TPS)制定方案,通过CT影像引导植入125I粒子,并行剂量学验证和定期复查。结果 89例125I植入组和25例化疗对照组总有效率分别为97%和20%,两者具有显著性差异(χ2=64.92,P<0.01)。结论 125I植入治疗晚期NSCLC具有肯定的疗效和较轻微的副作用。

     

    Abstract: Objective To analyze, research and process curative effect and damaging effect of terminal non small cell lung carcinoma(NSCLC). Methods Under treatment planning system and CT image guided, 125I seeds were implanted in 89 case confirmed terminal NSCLC and posologic validation and recheck termly. Results The total efficient rate of brachytherapy and chemotherapy group respectively is 97% and 20%. They have the significant difference(χ2=64.92, P<0.01). Conclusion The therapy of radioactive 125I seeds implantation is resulfful. But it unavoidably has low-grade damaging effect.

     

/

返回文章
返回